Last reviewed · How we verify

NCT05942560

Effects of CBT-Based Intervention Among Patients With Liver Cancer

Not yet recruiting NA Last updated 22 November 2023
What this trial tests

NA trial testing Cognitive behavioural therapy-based intervention in Depression in 160 participants. Not yet recruiting.

Timeline
30 December 2023
Primary endpoint
30 June 2026
30 June 2029

Quick facts

Lead sponsorThe Nethersole School of Nursing
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment160
Start date30 December 2023
Primary completion30 June 2026
Estimated completion30 June 2029
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The Nethersole School of Nursing

Who can join

18 and older, any sex, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the effects of a CBT- based intervention on depression, anxiety, immune function, quality of life, and overall survival. It also explores if the effects of the intervention on immune function and quality of life are mediated through the improvements in depression and anxiety among patients with liver cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment.
    Liu Y, Yang H, Li T, Zhang N. · · 2024 · cited 23× · PMID 39295859 · DOI 10.3389/fimmu.2024.1460282

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

Other The Nethersole School of Nursing trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05942560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing